Petros Pharmaceuticals, Inc. (PTPI) 是一家上市公司 属于 医疗保健 板块，经营于 制药 - 专科与仿制药 行业. 公司总部位于 New York City, NY, 美国. 现任CEO为 Fady Boctor.
PTPI 拥有 IPO日期为 2020-12-02, 18 名全职员工, 在 NASDAQ Capital Marke, 市值为 $180.73K.
Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics. The company engages in the commercialization and development of Stendra, an PDE-5 inhibitor prescription medication for the treatment of erectile dysfunction (ED). It also develops and commercializes H100, a patented topical formulation candidate for the treatment of acute Peyronie's disease. The company markets its line of ED products in the form of vacuum erection device products. Petros Pharmaceuticals, Inc. is based in New York, New York.
